Dr. Diego Guarin has contributed to the development of Pharmacoeconomics and Outcomes Research in Latin America serving as chair of two ISPOR Latin American Consortium Committees (2010-12/2014-16) and being appointed as the first representative of Latin America at the ISPOR Health Science Policy Council (2017-2019). He is also member of HTAi interest group on Developing Countries since 2009. In addition, he has been a company representative at FIFARMA, the Latin American Federation of the Pharmaceutical Industry, serving as co-chair of to working groups (Value and Access to Innovation 2017-20/2021-22 and Health Policies 2022-to date).

Dr. Guarin graduated as Medical Doctor from Universidad del Rosario-1653 (Colombia) and holds master’s in Public Health in Developing Countries from the London School of Hygiene and Tropical Medicine (UK), Health Economics and Pharmacoeconomics from Universitat Pompeu Fabra (Spain) and in Health Economics Policy and Management from the London School of Economics and Political Science (UK).